Xtx Topco LTD Lipocine Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.73 - $1.34 $28,730 - $52,738	-39,357 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.89 - $1.85 $35,027 - $72,810	39,357 New	39,357 $54,000
Q4 2021 Feb 11, 2022	SELL	$0.99 - $1.2 $28,474 - $34,514	-28,762 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.08 - $1.49 $8,700 - $12,003	8,056 Added 38.91%	28,762 $31,000
Q2 2021 Aug 12, 2021	SELL	$1.17 - $1.59 $10,790 - $14,664	-9,223 Reduced 30.82%	20,706 $29,000

Q1 2021 May 14, 2021	BUY	$1.38 - $2.28 $41,302 - $68,238	29,929 New	29,929 $45,000

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $729M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.